ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Graft survival"

  • 2016 American Transplant Congress

    Results from 100 Consecutive Donation-After-Circulatory Death (DCD) Liver Transplants Using a Thrombolytic Protocol.

    J. Seal, H. Bohorquez, N. Battula, E. Ahmed, D. Bruce, I. Carmody, R. Trevor, G. Tyson, S. Joshi, N. Bzowej, G. Therapondas, N. Girgrah, A. Cohen, G. Loss.

    Multi-Organ Transplant Institute, Ochsner Clinic Foundation, New Orleans, LA.

    Background: In early 2010, our center implemented a thrombolytic protocol for DCD liver transplantation in an effort to reduce biliary complications and improve graft survival.…
  • 2016 American Transplant Congress

    Relationship Between Dialisys Duration and Prevalence of Cardiovascular Diseases in Kidney Transplantation Recipients.

    K. Unagami,1 M. Okumi,2 T. Hirai,2 Y. Okabe,3 K. Masutani,4 T. Shimizu,2 K. Omoto,2 M. Inui,2 H. Ishida,2 T. Kitazono,4 K. Nitta,1 K. Tanabe,2 The Japan Academic Consortium of Kidney Transplantation (JACK).

    1Nephrology, Tokyo Women's Medical University, Tokyo, Japan; 2Urology, Tokyo Women's Medical University, Tokyo, Japan; 3Surgery, Kyushu University, Fukuoka, Japan; 4Medicine and Clinical Science, Kyushu University, Fukuoka, Japan.

    Background: Among kidney transplantation (KTx) recipients, the prevalence of Cardiovascular disease (CVD) is high. However, to our knowledge, the relationship between the prevalence of CVD…
  • 2016 American Transplant Congress

    When Liver Transplants and Procurement Occur at One Location – A National Study of Graft Survivals.

    J. Ortiz,1 N. Koizumi,2 C. Kwon,2 Y. Zhang,2 C. Ortiz.3

    1University of Toledo, Toledo, OH; 2George Mason University, Fairfax, VA; 3Bucknell University, Lewisburg, PA.

    Organ procurement and placement processes entail complex scheduling, logistics and other administrative challenges, especially when organs travel outside the procuring Organ Procurement Organization (OPO) area.…
  • 2016 American Transplant Congress

    Outcomes of Pediatric en Bloc Kidney (PeB) Grafts After Loss of a Single Kidney.

    C. Santhanakrishnan, R. Perez, J. McVicar, J. Sageshima, C. Troppmannn.

    Division of Transplantation, Dept of Surgery, Univ of Calif Davis Medical Center, Sacramento, CA.

    Background: Transplantation (Tx) of PeB kidney grafts has been shown to result in good long-term outcomes. However, the fate of PeB grafts that suffer loss…
  • 2016 American Transplant Congress

    Ischemia Reperfusion Induced Murine Heart Transplant Rejection Is Complement Dependent.

    N. Chun,1 M. Zhang,2 R. Fairchild,3 P. Heeger.1

    1Medicine, Icahn School of Medicine at Mount Sinai, NY, NY; 2Anesthesia, SUNY Downstate, NY, NY; 3Immunology, Cleveland Clinic, Cleveland, OH.

    Increased posttransplant ischemia reperfusion injury (IRI) prevents costimulatory blockade induced heart graft survival but mechanisms linking innate and adaptive immunity are poorly understood. Based on…
  • 2016 American Transplant Congress

    Everolimus Plus Reduced-Exposure Cyclosporin versus Mycophenolic Acid Plus Cyclosporin: Seven-Year Follow-Up of Australia and New Zealand Kidney Transplant Recipients in the A2309 Study.

    S. Chadban,1 H. Pilmore,2 G. Russ,3 J. Kanellis,4 S. Campbell,5 P. O'Connell,6 W. Lim,7 M. Lutherborrow,8 N. Kurstjens,8 R. Walker.9

    1Renal Medicine, Royal Prince Alfred Hospital, Sydney, Australia; 2Auckland Renal Transplant, Auckland City Hospital, Auckland, New Zealand; 3Central Northern Adelaide Ranel and Transplantation Service, Royal Adelaide Hospital, Adelaide, Australia; 4Renal Medicine, Monash Medical Centre, Melbourne, Australia; 5University of Queensland, Princess Alexandra Hospital, Queensland, Australia; 6Renal Medicine, Westmead Hospital, Sydney, Australia; 7WA Liver and Kidney Transplant Service, Sir Charles Gairdner Hospital, Perth, Australia; 8Novartis Pharmaceuticals, Sydney, Australia; 9Renal Medicine, Alfred Hospital, Melbourne, Australia.

    A2309 was a 2-year, phase III randomized controlled trial evaluating the effect on graft and patient outcomes of three groups:1.5mg everolimus plus low exposure cyclosporine…
  • 2016 American Transplant Congress

    Impact of Simultaneous Pancreas-Kidney Transplantation versus Kidney Transplant Alone on Patient and Graft Survival in Type 2 Diabetics with Elevated BMI.

    S. Singh,1,2 S. Kim.1,2,3,4

    1Division of Nephrology, Department of Medicine, University of Toronto, Toronto, Canada; 2Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada; 3Division of Nephrology and the Multi-Organ Transplant Program, University Health Network, Toronto General Hospital, Toronto, Canada; 4Division of Nephrology and the Kidney Transplant Program, St. Michael's Hospital, Toronto, Canada.

    Background: Simultaneous Pancreas-Kidney transplantation (SPKT) is becoming increasingly common in patients with Type 2 diabetes (T2DM). The BMI threshold for listing for SPKT in this…
  • 2016 American Transplant Congress

    Center and Surgeons' Experience Improves Outcome in Adult-to-Adult Living Donor Liver Transplantation: Validation of the Report of the A2ALL Consortium.

    S. Nagai, A. Yoshida, M. Rizzari, K. Collins, D. Kim, M. Abouljoud.

    Transplant and Hepatobiliary Surgery, Henry Ford Hospital, Detroit, MI.

    Background: Adult-to-adult living donor liver transplantation cohort study (A2ALL) has reported improved outcomes in centers with greater experience (>20 cases). The aim of this study…
  • 2016 American Transplant Congress

    The Use of Kidney Donors Older Than 80 Years Does Not Affect Graft Survival in the Medium Term.

    A. Fernández,1 J. González,2 C. Galeano,1 S. Elias,1 S. Jimenez,1 F. Caravaca,1 S. Pampa,1 R. Marcen.1

    1Nephrology, Hospital Ramón y Cajal, Madrid, Spain; 2Nephrology, Hospital de León, Leon, Spain.

    INTRODUCTION:Kidney transplantation is the best option for renal replacement therapy. One of its main limitations is the organs shortage. We analyzed the results in kidney…
  • 2016 American Transplant Congress

    Role of Induction Therapy in Low Immune Risk Kidney Transplant Recipients.

    B. Chopra, K. Sureshkumar.

    Nephrology and Hypertension, Allegheny General Hospital, Pittsburgh, PA.

    Induction therapy improves outcomes in kidney transplant recipients (KTRs) by reducing early acute rejection. In the current era of potent maintenance immunosuppression, the role of…
  • « Previous Page
  • 1
  • …
  • 87
  • 88
  • 89
  • 90
  • 91
  • …
  • 113
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences